Clinical Studies Find sam® Developed by ZetrOZ Systems Effectively Treats Osteoarthritis

Clinical Studies Find sam® Developed by ZetrOZ Systems Effectively Treats Osteoarthritis

ZetrOZ Systems, a leading medical device manufacturer and sustained acoustic medicine pipeline development company, announces that a series of studies from 2014 through 2020 found that its sam® (sustained acoustic medicine) technology reduces pain and improves joint function in patients with knee osteoarthritis. In addition, studies show that sam® can cut the overall cost of treatment in half, by $27,000 on average, and reduce lost work time. Read more >>

Share this post